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SUMMARY 
• The ratsubmandibular glands (SMG) are innervated 
by both the sympathetic and the parasympathetic branches of 
the autonomic nervous system which, in turn,regulate the 
secretory functions of the glands. Parasympathetic innerva- 
tion of rat SMG is present at birth, whereas sympathetic nerve 
fibers reach the glands by postnatal day 5. Isoproterenol 
(IPR), a fi-adrenoceptor agonist, induces hypertrophic and 
hyperplastic enlargements of rat salivary glands, and induces 
the expression of a number of genes, including cystatin S, a 
member of family 2 of the cysteine proteinase inhibitor super- 
family. Cystatin S gene expression is tissue- and cell type- 
specific, occurs transiently during development, and is not 
observed in adult animals. Sympathetic denervation of adult 
SMG, achieved by removing the superior cervical ganglion, 
reduces the induction of the cystatin S gene by a single 
injection of IPR. In addition, recent data indicate that the j3- 
receptors present early in the developing SMG are functional 
and are capable of responding to IPR by increasing the ex 
pression of the cystatin S gene, even when sympathetic nerve 
fibers have not reached the gland. The level of I PR-induced 
cystatin S mRNA remains constant until day 8, at which time 
a dramatic induction of cystatin S mRNA is observed. This 
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statistically significant increase in cystatin S mRNA at day 8 
was diminished, but not completely suppressed, upon sympa-
thectomy of one day old animals. These data indicate that an 
intact sympathetic innervation is not requisite for induction of 
cystatin S gene expression by IPR in developing SMG. However, 
sympathetic innervation is required for the full IPR response of 
the cystatin S gene in these glands. Collectively, these 
experiments suggest that factor(s) derived from the 
sympathetic nervous system participate in IP R-induced 
expression of the cystatin S gene in the rat SMG. (Biomed Rev 
1998; 9:33-46) 
INTRODUCTION 
• Proteolysis is a common mechanism of activation or 
inactivation of polypeptides that perform important physiolo 
gical functions in all living creatures. There are four major 
classes of enzymes responsible for these activities in eukary- 
otes. They are classified on the basis of the amino acid at their 
active sites or their dependence upon metal ions, that is, 
cysteine-, serine- and aspartylproteases, and metalloproteases. 
Cystatins are naturally occurring cysteine proteinase inhibitors 
present in a variety of tissues and body fluids. All known 
mammalian cys-tatins are members of an evolutionarily-related 
superfamily of proteinase inhibitors consisting of three major 
families, family 1 (the stefms), family 2 (the cystatins), family 3 
(kininogens), as well as other cystatin-related proteins. These 
families are distinguished on the basis of their polypeptide chain 
complexity and their cellular location (1,2). The cystatins no 
doubt play a major role in mediating normal physiological 
processes in which cysteine proteinases are involved, e. g. 
  
  
intracellular catabolism of polypeptides and proteins (3), 
processing of proenzymes and prohormones (4), extracellular 
degradation of collagen (5), bone resorption (6), and apoptosis 
(7,8). They are also involved in pathophysiological processes 
such as prevention of penetration and destruction of tissues 
by bacteria(9,10) and viruses (1 l,12),periodontal, lung, 
andjoint inflammatory diseases (13), regulation and assembly 
of many viral proteins including those of HI V-1(12), and cancer 
progression (14). Thus, impairment of cystatin function can 
lead to uncontrolled proteolysis and therefore to devastating 
and irreversible damage. 
CYSTATINS IN DISEASES 
• The importance of cystatins is further emphasized by 
diseases that are directly caused by genetic alterations of 
cystatins, and diseases that are associated with decreased 
quantities of cystatins. Cystatin C, found in highest concentra 
tions in mother's milk, semen, and spinal fluid, is unusually low 
in the cerebrospinal fluid of patients with multiple sclerosis (15). 
A defective cystatin has been identified in the skeletal muscle 
of mice with hereditary muscular dystrophy (16). Icelandic pa 
tients with familial amyloid angiopathy, or hereditary cerebral 
hemorrhagia, have an autosomal dominant form of amyloidosis 
which results in massive cerebral hemorrhages andthrombotic 
strokes leading to death. This disease is a direct result of an 
autosomal dominant variant form of cystatin C that has a point 
mutation in the second exon of the cystatin C gene - C AG instead 
of CTG, a glutamine is substituted for a leucine residue (17-20). 
Significantly, two mutations (3-'splice site mutation and stop 
codon mutation) in the cystatin B gene have been found to be 
directly responsible for the disease progressive myoclonus epi 
lepsy, an autosomal recessive inherited form of epilepsy (21). 
SALIVARY CYSTATI MS 
• Cystatins are widely distributed in human tissues and 
body fluids. They are present at high levels in saliva, cerebrospi 
nal fluid, milk, tears and amniotic fluid where they constitute an 
important barrier against pathogens. Salivary glands of mam 
mals are specialized to produce secretions that are important in 
early digestive processes and that bathe and protect the oral 
cavity, and the secreted cystatins are thought to play a major 
role in this process. The salivary cystatins, first identified in 
human saliva as cysteine-containing phosphoproteins (22,23), 
were purified by several investigators, and a salivary gland- 
specific cystatin, cystatin S, was found to be synthesized in the 
acinar eel Is of submandibular and parotid glands (24-26); cysta 
tin S was absent fronxbronchial mucosal glands and pancreas. 
Isemura et al (24,25) demonstrated that whole human saliva 
contains at least eight cystatins (S 1 to S8), differing only in their 
N-terminal region. Additional cystatins have been isolated from 
whole human saliva (SA, SN) and human submaxillary/sublin- 
gual saliva (SA-1). These cystatins differ in their isoelectric 
points, inhibitory specificities, and length of their polypeptide 
chains. Three genes encoding cystatins are produced inhuman 
salivary glands; one of these is a pseudogene, and the other two 
encode cystatins S and SN (27). Genomic Southern blots 
indicate that cystatin genes expressed in human salivary 
glands form a multigene family with at least seven members. 
Subsequently, a rat salivary cysteine proteinase inhibitor gene, 
cystatin S, was identified (28). It was demonstrated that rat 
cystatin S is specific for cysteine proteinases. The expression of 
the rat cystatin S gene is tissue- and cell type-specific, and 
can be precociously induced in both the SMG and the parotid 
glands by the (3-adrenergic agonist isoproterenol (IPR) (29). 
The rat cystatin S gene is also unique in that it is expressed early 
during development of rat SMG, and that it can be induced, 
by (3-adrenoceptor-mediated mechanisms, to express in adult 
glands where it is normally turned off. 
REGULATION OF GYSTATIN S GEME EXPRESSION 
• Little is known about the regulation of cystatin genes. 
Our laboratory was the first to demonstrate |3-adrenergic regu 
lation of expression of a cystatin gene, rat cystatin S, and is 
currently investigating the neural mechanisms regulating sali 
vary cystatin genes, using the rat cystatin S gene as a prototype. 
The rat cystatin S gene is expressed postnatally in the develo 
ping SMG; the concentration of cystatin S mRNA reaches peak 
levels at 28 days after birth. Cystatin S mRNA subsequently 
declines to barely detectable levels at 32 days and to undetect- 
able levels at 35 days following birth (29). Regulation of the 
cystatin S gene by the autonomic nervous system is suggested 
by its inducibility in the SMG, as well as the parotid gland, by 
the p-adrenoreceptor agonist IPR(28,30). IPR induces changes 
in salivary glands that mimic normal development of the glands. 
It has profound effects on the growth and function of SMG and 
parotid gland of rats and mice, stimulating DNA synthesis, hy~ 
perplastic/hypertrophic enlargements of the glands, and syn 
thesis/release of secretory proteins (31,32). In addition, IPR 
accelerates differentiation of acinar cells in developing SMG, 
and induces the precocious expression of the cystatin S gene 
(28,29). Upon IPR induction, cystatin S mRNA is approximately 
20-fold more abundant in the rat SMG than in the partoid gland, 
and cystatin S mRNA is undetectable in the sublingual gland, 
suggesting that tissue-specific factors participate in its regula 
tion. Our earlier data suggested that sex hormones might also 
play a role in the regulation of the cystatin S gene, since its res 
ponse to IPR was 4-fold higher in adult females than in adult 
males (30). In order to examine regulation of cystatin S gene 
expression,wehavesequenced the gene(33),and 1911 bpofS'- 
flanking DNA. The nucleotide sequence of the gene encoding 
the precursor form of rat cystatin S shows that the organization 
of the rat cystatin S gene is simi lar to the human genes encoding 
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have the same number of introns and exons, and similar exon-
intron structure. A comparison of the DNA and protein 
sequence of these human cystatins and the rat cystatin S gene 
shows significant identity (50% for protein, 60% for DNA). 
Sequence of the 5 '-flanking region of the rat cystatin S gene (Fig. 1) 
revealed CAAT (-48) and TATA (-28) boxes upstream of the 
initiation codon, as well as several possible regulatory 
sequences that resemble those identified for other hormonally 
responsive eukaryotic genes. The sequence 5 '-TGACATCA-3' 
located at position -1777 in the 5' -flanking region of the cystatin S 
gene is a potential CREB/AP-1 binding site (34-37). Two 
potential identical glucocorticoid receptor binding sites are 
located atpositions -1487 and -187 (5 '-TGTGAT-3') (3 8); there 
isapotentialAP-2bindingsite(-194,TGGGGA)(39)adjacentto 
the putative glucocorticoid receptor binding site located at 
position -187. In addition, another potential glucocorticoid/ 
progesterone receptor responsive element, 5'-TGTTCT-3', is 
located at position -753 (40,41). Interestingly, the 5'-flanking 
region of the gene contains three regions that are common to all 
known sequenced salivary gland-specific genes (Table 1). In 
the rat Cys S gene they are: I, -711 TTTCCTACC; II, -865 
AGTGACCCTA; III, -947 TGAGGGAGTG. The 5 '-flanking region 
of the rat cystatin S gene also contains a GT-rich region of 27 GT 
repeats that are located between domains II and III; this GT 
repeat region is flanked by TTT. The first intron sequence also 
contains another consensus CRE highly homologous to one 
found in the IPR-inducible mouse and hamster proline-rich-protein 
(PRP) encoding genes (42). 
The expression of the cystatin S gene induced by IPR in the 
SMG of adult rats seems to be regulated through the (31-adre-
nergic receptor-cAMP-PKA pathway, since the effect of IPR is 
blocked by specific (31-, but not by p2-adrenergic antagonists 
(43). The effects of (3 1 -adrenergic receptor stimulation are 
mediated by the adenylatecyclase-cAMPpathway. 
Administration of IPR leads to a rapid increase of intracellular 
cAMP (44,45). Transcription of a large number of eukaryotic 
genes including the proto-oncogene c-fos, somatostatin, tyrosine 
hydroxylase, proenkephalin.vasoactive intestinal 
peptide(V!P),a-chorionic gonadotropin, and 
phosphoenolpyruvate carboxykinase is activated in response to 
increased intracellular levels of cAMP. Each of these genes has 
a common and well characterized short 
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Nineteen hundred and eleven base pairs (1911 bp) of 5'-flanking sequence of the rat cystatin S (r Cystatin S) gene were compared 
with 251 bp of the human salivary amylase gene (hAMY 1C; Ref 118), 1 kb each of the human proline-rich proteins (hPRPs I and II; 
Ref 119), macaque proline rich protein gene (macPRP, MnP4; Ref 120), mouse proline-rich protein gene (mPRP, Ref 121), and the parotid 
secretory protein gene (mPsp, Ref 122). Approximately 360 bp of the 5 '-flanking region of the human salivary cystatin genes CST1 
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Figure 1. Sequence of 5 '-flanking region of the rat cystatin Sgene. The DNA sequence includes 1911 bp 5' of the transcription 
start-site and 50 bp past the transcription start-site. The CCAA T box is located at position -48; the TA TA box is located at -28. 
Three potential glucocorticoid responsive elements are located at position -1487, -753, and -187, and an adjacent AP-2 
binding site is located at-194. A potential CREB/AP-1 binding site is located at position -1777. Three salivary gland-specific 
domains are located at -711, -865, and -947. A GT-rich region is identified beginning at -924. 
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palindromic core motif 5-TGACGTCA-3, the cAMP response 
element, in their promoter sequence (46-50). The effect of cAMP 
on gene transcription is usually rapid and does not require 
newly synthesized protein(s), suggesting that transcriptional 
modulation bye AMP involves the covalent modification rather 
than de novo synthesis of nuclear factors (49,51). If an increase of 
intracellular cAMP is sufficient for the induction of cystatin S 
gene expression in acinar cells, one would expect the gene to be 
expressed in vivo in response to IPR even in the presence of 
protein synthesis inhibitors. Results presented here, however, 
show that IPR-induced expression of the cystatin S gene in rat 
SMG is dependent on newly synthesized proteins, since its 
expression is completely blocked by simultaneous treatment of 
the animals with cycloheximide (Fig. 2). 
Based on our previous findings that IPR-induced levels of 
steady-state cystatin S mRNA in SMG is greater in adult female 
than in adult male animals (29), we hypothesized that gonadal 
steroids and glucocorticoids participated in IPR-regulation of 
the cystatin S gene. Thus, we examined the in vivo regulation of 
the cystatin S gene by gonadal steroids and/or glucocorticoids. 
We quantitated the steady-state levels of cystatin mRNA in 
intact and/or adrenalectomized (adx) and castrated/ovariecto-
mized (cx/ovx) animals in order to determine if gonadal hormones 
or glucocorticoids participate in the regulation of cystatin S 
gene expression. The data indicated that the differential 
expression of the cystatin S gene in female vs male SMG is not 
only regulated by the p-adrenoreceptor-mediated pathway, but 
other factors and/or steroid hormones also play a part in its 
regulation. Furthermore, dexamethasone appears to be acting in a 
gonadal hormone-dependent fashion in its participation in 
regulating the cystatin S gene, it negatively regulates the cystatin 
S gene in females (52). 
AUTONOMIC NERVOUS SYSTEM AND CYSTATIN 
S GENE EXPRESSION 
• Both branches of the autonomic nervous system 
innervate the major salivary glands of the rat, and regulate the 
volume and composition of saliva (53). In adult animals, stimu 
lation of cholinergic and cc-adrenoreceptors elicits the formation 
of moderate amounts of saliva rich in electrolytes, whereas 
stimulation of (3-adrenoreceptors stimulates secretion of small 
amounts of salivarich in proteins (54-57). It has long been known 
that the size of salivary glands is influenced by the autonomic 
nervous system, and that in adult rats prolonged electrical 
stimulation of the sympathetic branch of the autonomic nervous 
system via the superior cervical ganglion (SCG) causes enlar 
gement of salivary glands by increasing both cell size and cell 
number (59,60). Denervation of adrenergic target tissues leads 
to compensatory upregulation of a- and p-adrenergic recep 
tors, and to supersensitive responses to adrenergic agonists. 
This supersensitivity has been documented, for example, in rat 
cerebral cortex(61), raturinarybladder(62), ratpineal gland (63), rat 
parotid gland (64), and in smooth muscles of rabbit iris (65). 
Surgical or chemical sympathetic denervation in adult rats 
results in supersensitivity of the SMG to the p-adrenergic sia-
logogic effects of norepinephrine and IPR (66-71). Catechola-
mine stores in sympathetically innervated organs are depleted 
rapidly after a single administration of reserpine, and the 








Figure 2. Northern blot analyses of the effect of cycloheximide 
on [PR-induced cystatin S gene expression. Five micro-grams 
of total RNA extracted from submandibular glands was 
electrophoresedinpolyacrylamide-nreagels. The RNA, 
dissolved in sterile distilled water containing 0.1 mM eth-
ylenediamine tetraacetic acid (EDTA), was mixed with 10 
fjlof'loadingbuffer (80%formamide, WmMEDTA, O.Smg/ 
mlxylenecyanol, 0.5 mg/mlbromophenol blue) andelectro-
phoresed at 250 volts for 1 hr in 4% polyacrylamide-8 M 
urea gels in IX TBE buffer (89 mM Tris-HCl, 89 mM boric 
acid, and 2 mM EDTA), using a minigel system from Hoefer 
Scientific Instruments. As molecular weight markers, 5000 
c.p.m. ofa32P-labeledDNA ladder (UnitedStates Biochemical 
Corporation) were used. The RNA was electrotransferred for 1 
hr at 250 mamps in 0.5X TBE onto Gene Screen Plus 
membranes. The RNA blots were hybridized overnight at 
65 °C with the 
i2
P-labeled cystatin S riboprobe and a 
cyclophilin riboprobe, washed according to Shaw et al 
(28), and analyzed in the Phosphorlmager (Molecular 
Dynamics). Lanes 1 and 2 are from two adult female rats 
treatedwith cycloheximide alone, lanes 3 and4 arefrom two 
female rats treated with IPR. Lanes 5 and 6 arefrom two 
female rats treated with cycloheximide and IPR 
simultaneously. 
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result, there is a decreased concentration of norepinephrine at 
the synapse, a marked increase in adrenergic receptors, (73), and 
also supersensitivity to IPR in salivary glands (58,74). Binding 
studies have demonstrated that the increase in the [3-adrener-gic 
response in sympathectomized rat SMG is paralleled by an 
increase in the density of the (31 -adrenergic receptors in 
membranes prepared from the glands, with no change in 
binding affinity (70,72,75). The supersensitivity of the SMG 
is also illustrated by the increase in intracellular cAMP in 
response to IPR in cells from SMG of rats previously treated with 
reserpine as compared with cells from glands of control animals 
(74). Basal c AMP levels were similar between control (1 A+l- 0.3 
pmol/mg) andreserpine-treated glands (2.0+/-0.6pmol/mg). 
However,the increase in intracellular c AMP in response to IPR 
was markedly accentuated in glands from reserpine treated rats 
(79-fold increase) compared with control glands (13-fold 
increase; 74). It has also been demonstrated that the SMG 
remains super-sensitive to norepinephrine 6 weeks after 
sympathetomy (76). 
We have analyzed the effect of sympathectomy of the SMG of 
adult female rats, by removing the superior cervical ganglion 
(bilaterally or unilaterally), or by chemical sympathectomy by 
treatment with reserpine, on IPR-induced expression of the 
cystatin S gene. The amount of cystatin S mRNA. as determined 
by quantitation of Northern blots, in the SMG of bilaterally 
sympathectomized, IPR-treated animals was reduced to 47 % 
that of SMG of sham operated, IPR-treated animals. In unilaterally 
sympathectomized, IPR-treated rats, the amount of cystatin S 
mRNA in the sympathectomized SMG was 44 % that of intact 
glands. The amount of cystatin S mRNA in the glands of adult 
rats treated with a single dose of reserpine for each of 2 days 24 
hr before a single IPR injection was 30 % that of the non-
reserpine, IPR-treated glands (see Table 2; 77). These results 
were somewhat unexpected. If, cystatin S gene expression is 
regulated directly by the p 1 -adrenergic receptor pathway, one 
would have expected one of the following results: (/) overexpres-
sion of the cystatin S gene in response to IPR in sympathectomized 
animals since P1 -adrenoreceptors are upregulated upon surgical 
sympathectomy or reserpine treatment and SMG become super- 
sensitive to p-adrenergic agonists, and (if) alternatively, if the 
intracellular concentration of cAMP reached in the SMG of 
nondenervated rats upon treatment with IPR is sufficient to 
produce the maximal level of expression of the cystatin S gene, it 
would be expected that in the denervated glands (which are 
supersensitive to IPR), a further increase in the intracellular 
concentration of cAMP in response to IPR would not produce 
any significant change in the levels of cystatin S gene 
expression. However, both bilateral and unilateral sympathetic 
de-nervation reduced the levels of cystatin S gene expression 
in response to IPR, and a comparable effect was observed in 
rats previously treated with reserpine. In other words, the 
expression of the rat cystatin S gene mediated by pi-adrenergic 
receptor stimulation was partially blocked by sympathetic 
denervation, indicating there is clearly a lack of correlation 
between cAMP accumulation and cystatin S gene expression . 
There are several precedents in the literature for similar 
phenomena. It has been found that the ability of IPR to 
stimulate ornithine decarboxylase (ODC), a growth related 
enzyme, in heart, lung and kidney is reduced by neonatal 
sympathectomy (78). P-adrenergic receptors are not coupled 
directly to ODC gene expression, but rather receptor 
stimulation initiates the synthesis of new ODC molecules 
through a cAMP-dependent process mediated by the 
protooncogene c-fos. Sympathetic denervation by 6-
hydroxydopamine produces a loss of the ability of stimulated 
p-adrenoceptors to induce expression of the protooncogene c-
fos, resulting in reduced expression of ODC in the rat 
cerebellum (79). There are also interesting examples in the rat 
parotid gland resembling the reduction of cystatin S gene 
expression in response to IPR in the SMG of sympathectomized 
rats. The sympathetic and parasympathetic nervous systems 
have a regulatory role on PRP synthesis in parotid glands, 
since there are significant decreases in the synthesis of PRP in 
the denervated parotid glands of unilaterally sympathectomized 
(14 % reduced), parasympathectomized (reduced by 
approximately 16 %), and double denervated rats 
(sympathectomized and parasympathectomized; 26 % 
reduced). The effect is additive as double denervated glands 
show changes 









Sx. sympathectomy bv removing the superior cervical ganglion (a). Animals unilaterally sympathectomized at one day of age (b). 
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approximately equal to the combined individual changes of 
sympathectomyandparasympathectomy(80). Maintenance of 
rats exclusively on a liquid diet results in a reduction in the size of 
the parotid gland 4 days after introduction of the liquid diet (81). 
However, reintroduction of a solid diet restores the gland size and 
also induces a burst in cell proliferation that peaks after 2 days 
ofthe dietary change (82). This dietary change is accompanied by 
increased masticatory activity, and growth responses appear to 
be mediated by the autonomic nervous system (83). A marked 
increase in the activity and cell surface levels of the enzyme pi-4 
galactosyltransferase is also induced in rat parotid glands 
when autonomically mediated activity of the gland is increased 
by a dietary change from all liquid to solid food (84). The 
same effect is observed following increased acinar cell 
proliferation ofthe parotid gland that occurs after chronic 
exposure ofthe rats to IPR (85). However, removal of either 
parasympathetic or sympathetic innervation to the parotid gland 
prior to the dietary change results in a partial inhibition ofthe 
increase in p 1 -4 galactosyltransferase enzymatic activity: in 
parasympathectomized glands the increase in enzyme activity was 
51 % that ofthe innervated glands, and with sympathec-tomy, it 
was 41 % (86). This picture resembles the observed reduction of 
IPR-induced expression of the cystatin S gene in sympath-
ectomized SMG, and strongly suggests that the expression ofthe 
cystatin S gene in the SMG, pl-4 galactosyltransferase and 
proline-rich proteins in the parotid gland, and probably other 
genes regulated through the p-adrenergic pathway (like ODC), 
require the participation of additional factors 
from the sympathetic and/or parasympathetic nervous system. 
Tissue slices of SMG respond to norepinephrine and IPR in 
vitro, as determined by an increase in the levels of cAMP (73, 
74). Isolated rat SMG acini are responsive to a-and P-adrenergic 
agonists as indicated by increased secretion of mucin in 
response to norepinephrine and IPR (45,87-89), dibutyryl-
cAMP (90), and forskolin (45,87). Responsiveness ofthe SMG to 
IPR in vitro has also been documented by the function of 
stimulatory G proteins (Gs), increased adenylate cyclase activity 
(91), and increased levels of intracellular cAMP (45). However, 
cystatin S gene expression is not induced in vitro in primary 
cultures of SMG cells in response to IPR. This lack of inducibility 
of cystatin S gene expression has also been observed in primary 
cultures or tissue slices of SMG treated with norepinephrine, 
forskolin, dibutyryl-cAMP, p-estradiol, ordexamethasone. No 
induction of cystatin S gene expression has been detected by 
RT-PCR analyses in primary cultures under different 
conditions of (0 serum concentration (from 0-10% PCS), (if) 
surface where the cells were grown (plastic, collagen, laminin), (Hi) 
time of exposure to the agonists, and (/v) varying concentration of 
IPR (Fig. 3). 
Treatment of adult rats with 6-hydroxydopamine, which depletes 
norepinephrine stores, destroys the ability of nerves to take up 
exogenous norepinephrine, selectively destroys the sympathetic 
nerve terminals (92-94), and greatly reduces DNA synthesis in 
SMG of IPR-treated animals. A single dose of 6-
hydroxydopamine given one hr prior to the administration of IPR 
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Figure 3. Reverse-transcriptase analysis of cystatin S gene expression in control and IPR-treated cells from primary cultures of rat 
siibmandibular glands. Cystatin S mRNA was amplified using a GenAmp kit (Perkin Elmer Cetus, Branchbwg, NJ) following 
the manufacturers instructions. The PCR products were radioactively labeled using 0.1 /jM12P-ATP in each reaction tube during 
the last 5 cycles of amplification. As a template, 250 ng of total RNA were used; as a positive control, 100 ng of total RNA from 
siibmandibular glands of adult female rats treated with IPR were used. The upstream primer 5 '-
GATATCATGAACCACGAAAGA-3' that primes at postion +152 to +172, and the downstream primer 5 ' -
CTAGGTCACTTTCTGGGTGGC-3 ', priming at position +5024 to +5044 ofthe genomic DNA sequence, amplify a 296 bp DNA 
fragment from the cDNA. This distinguishes the PCR product from any potential amplification from the genomic DNA, that would 
produce a 4892 bp fragment. The amplification products were analyzed in 5%polyacrylamide-wea denaturing gels, transfered onto 
GeneScreen Plus membranes and analyzed in the Phosphorlmager. 
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Furthermore, the increase in DNA synthesis induced by IPR in 
vivo could not be reproduced in vitro. However, if rats are treated 
with IPR before the SMG are removed and cultured in vitro, DNA 
synthesis proceeds normally (Barka, personal communication), 
indicating that the DNA synthesis machinery ofthe SMG in 
culture remains functional. This suggests that the SMG require 
exposure in vivo to other sympathetic factor(s) in addition to IPR 
in order to be able to initiate the series of events leading 
successfully to initiation of DNA synthesis and replication. 
Again, experiments analyzing the increase in size ofthe rat parotid 
gland induced by a dietary change from all liquid to solid food, as 
discussed previously, provides additional support to this 
hypothesis. This change in diet is followed by an average increase of 
200% in 3 H-thymidine uptake into the parotid gland. However, 
removal of either parasympathetic or sympathetic in-nervation to 
the parotid gland prior to the dietary change resulted in a partial 
inhibition ofthe increase; values for the parasym-pathectomized 
gland were 51 % ofthose ofthe innervated gland, and the values 
for the sympathectomized parotid gland were 42% ofthose ofthe 
innervated gland. Removal of both autonomic nerves resulted in 
complete inhibition of 3H-thymidine uptake into the parotid 
glands (86). Altogether these data suggest that at least some 
ofthe effects of pl-adrenergic receptor stimulation in vivo, e.g. 
induction of DNA synthesis, and expression of specific set of 
genes, are not regulated directly via c AMP, and that additional 
factor(s) from sympathetic and/or parasympathetic nerve 
terminals are required. In addition, IPR-induced expression ofthe 
cystatin S gene in SMG is dependent on newly synthesized 
proteins, and cystatin S gene expression does not increase in the 
glands of sympathectomized rats treated with IPR, which are 
supersensitive to P-adrenergic agonists, compared to the 
nondenervated glands similarly treated with IPR. This indicates 
that the cystatin S gene is not directly regulated by the P-adrenergic 
receptor-c AMP pathway. However, pl-adrenergic specific 
antagonists completely block the ability of IPR to induce 
cystatin S gene expression (87). Collectively, these results 
indicate that the pl-adrenergic receptor pathway is necessary, 
but is not sufficient for the full IPR induction of cystatin S 
gene expression. 
In the rat SMG, the sympathetic nerves reach the gland by 
postnatal day 5, and activate secretion beginning on postnatal 
day 6 (97,98). p-adrenergic receptors are found on the surface of 
secretory cells as early as day 1 after birth (73), and they are 
functional since they are able to induce peroxidase secretion 
occurs in response to IPRstimulation (98,99). Our experiments 
are consistent with these reports and indicate that p-adrenergic 
receptors, present early in the developing rat SMG, are 
functional in that they are capable of responding to IPR 
stimulation by inducing the expression ofthe cystatin S gene 
even at 3 and 4 days of age, when sympathetic nerve fibers have 
not reached the gland (Fig. 4). This indicates that sympathetic 
innervation is not requisite for IPR-induced expression ofthe 
cystatin S 
gene. However, once the SMG is innervated by sympathetic 
nerve terminals, a more robust response to p-receptor stimulation 
is evident; the level of expression of cystatin S mRNA induced 
by IPR on postnatal day 8 is significantly higher than the levels 
during previous days (days 3-6) (Fig. 4). Morphological analyses 
of developing rat SMG show a continuous change in the 
composition of acinar and proacinar cell populations at 3,5, and 8 
days of age (100). The levels of cystatin mRNA in the SMG of IPR-
treated rats do not parallel the changes in acinar and proacinar 
cell populations, and are not significantly different between 3 
and 6 days of age, indicatingthat IPR-induced expression ofthe rat 
cystatin S gene during early development ofthe SMG is not j ust 
a function ofthe degree of differentiation ofthe acinar cells. 
Between days 4 and 6 after birth, the number of P-adrenergic 
receptors increases four-fold in the rat SMG. This increase in the 
number of (3-receptors coincides with the appearance of adult-
type stimulus-secretion coupling in the gland (98). However, 
increase in the number of P-adrenergic receptors is not paralleled 
by a similar increase in the level of expression ofthe cystatin S 
gene induced by IPR. As in the sympathectomized adult SMG, an 
increase in the number of p -adrenergic receptors was not 
accompanied by an increase in the expression ofthe cystatin S 
gene upon IPRtreatment. Membrane-associated adenylate cyclase 











Figure 4. Quantitative analyses of IPR-induced cystatin S 
gene expression during early development of the rat sub-
mandibnlar gland. Northern blots were qitantitated using 
the Phosphorlmager. The values are expressed as cystatin S 
mRNA light units (mean LU +/- SEM) and the data were 
analyzed by one wayANO VA and the post-hoc analysis was 
performed by the Tukey-HSD multiple range test with the 
significance level set at 0.05. Each data point represents the 
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is stimulated reproducibly 25-40 % by IPR, and membranes from 
glands of 6-day old animals show activation of adenylate cyc-
laseby IPR, similar to the 2.5 to 3.5-fold activation seen in the 
membranes of glands of adult rats (98). This indicates that by 
postnatal day 6, all the components of the (3 -adrenergic receptor 
signaling pathway are functionally coupled. Again, this increase in 
adenylate cyclase activation by IPR was not paralleled by a 
corresponding increase in the level of expression of cystatin S 
gene in the SMG of 6-day old rats. In summary, the development 
of SMG during the first postnatal week is a continuous process that 
is not reflected in a similar increase in the expression of the 
cystatin S gene induced by stimulation of the p -adreno-ceptors 
by an agonist. It was only after 6 days of age that a significant 
increase in cystatin S gene expression was observed in response 
to IPR, indicating that expression of the rat cystatin S gene is not 
entirely dependent on the p-receptor/cAMP path way, and, again, 
that additional factor(s), probably from the sympathetic nervous 
system, are required for its full response to IPR. 
In SMG of neonatal rats, chemical sympathectomy does not 
affect the time of appearance or the number of p-adrenergic 
receptors (101), indicating that the rat SMG does not become 
supersensitive after chemical sympathectomy during early 
development. In addition, sympathetic innervation of the rat 
SMG is not fully developed in newborn animals, and catechol-
ainine-containing neurons are not seen before day 5 of age (97, 
98). Such a non-innervated SMG offers an excellent experimental 
model to test the hypothesis that an intact sympathetic 
innervation is required for IPR-induced expression of the cystatin 
S gene. We tested this hypothesis by analyzing IPR-induced 
expression of the cystatin S gene in the rat SMG during early 
posnatal development, before and after the sympathetic nerve 
terminals reach the gland (as described above), and in sym-
pathectomized and nondenervated SMG of 4 and 8 days of age 
that have been unilaterally sympathectomized by removing 
the superior cervical ganglion on postnatal day 1. Since 
sympathetic fibers only reach the rat SMG by postnatal day 
5, unilateral sympathectomy on day 1 allows the analyses in the 
same animal, of the effect of IPR on cystatin S gene expression in 
partially or completely innervated glands, and glands that 
have never received sympathetic innervation. A comparison of 
the levels of cystatin S mRNA induced by IPR in innervated 
versus sympathectomized (sympathectomy at day 1) glands of 8-
day old animals indicates that sympathetic factor(s) are 
required for the full IPR-induction of cystatin S gene expression 
(Table 2). Moreover, these results are similar to those of the 
sympathetic denervation experiments in adult rats, and show 
that the reduction in the level of cystatin S gene expression 
induced by IPR is the result of depriving the denervated gland of 
sympathetic factor(s), independently of the condition of P-
adrenergic agonist supersensitivity in the SMG after 
sympathectomy, i.e. no supersensitivity in the newborns or 
super-sensitivitv in adults. 
A growing list of neuropeptides has been identified that appear to 
play an important role in the regulation of the SMG metabolism 
(102). Secretin and VIP enhance norepinephrine (NE)- and 
substance P (SP)-mediated secretion of fluid and protein from 
rat SMG (103,104). Calcitonin gene-related peptide (CGRP), SP 
and VIP, are most likely involved in the non-adrenergic, non-
cholinergic (NANC) secretion of saliva in response to 
stimulation of parasympathetic innervation (102,105,106). Galanin, 
another neurotransmitter, acts by inducing hyperpolarization 
of resting membrane potential in the rat SMG (107). There are 
limited physiological data on the effects of neuropeptide Y 
(NPY), the most abundant sympathetic neuropeptide in the 
salivary glands. Local, intraarterial infusion of NPY induces a 
dose-dependent vasoconstriction in the cat SMG (108), and 
NPY has also been proposed to be responsible for increased 
amylase secretion in parotid glands (109). Based on the 
distribution of NPY fibers, it has been suggested that in addition to 
its vascular effect, NPY may also have a functional role in the 
regulation of secretion from the parotid, sublingual and, 
possibly, the SMG of the rat (110). Interestingly, the rat SMG 
and parotid gland become supersensitive not only to P-
adrenergic agonists but also to sympathetic neuropeptides as a 
result of autonomic denervation (111). 
In addition to their role in synaptic communication, neurotran-
smitters are now recognized to play an important trophic role in 
cell differentiation within both the central nervous system and 
peripheral neural target tissues (79). Rats denervated at birth by 6-
hydroxy dopamine treatment showed an impaired response to 
vasopressin or angiotensin in stimulating cardiac ODC activity. 
Responsiveness of the kidney was affected only for vasopressin, 
and in the lung denervation had only transient effects on 
hormonal responses. This confirmed that sympathetic input is 
required for proper development of some, but not all, hormonal 
responses, and indicates that the role of neuronal factors is 
tissue specific (112). There is increasing evidence that 
neuropeptides exert receptor-mediated effects on gene 
expression. VIP, secretin, and peptide histidine isoleucine 
increased the expression of tyrosine hydroxylase gene, the rate-
limiting enzyme in the catecholamine biosynthetic pathway, and 
this effect is mediated by the cAMP second messenger pathway 
(113). VIP also stimulated c-fos and c-myc gene expression 
in several breast cancer cell lines (114). VIP andNE induced 
massive gly-cogen synthesis in mouse cortical astrocytes that 
was mediated by specific receptors coupled to the cAMP signal 
transduc-tion cascade in a protein synthesis-dependent fashion 
(115). More recently, it has been shown that glycogen 
synthesis induced by VIP, pituitary adenylate cyclase-activating 
peptide, and NE was mediated by induced expression of the 
transcription factors CC AAT/enhancer binding protein 
(C/EBP)-b and C/EBP-d(l 16). The fact that several 
neuropeptides regulate the expression of different transcription 
factors reinforces the notion that they play an important role in 
the physiology of their 
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peripheral target tissues, and suggests that they may establish 
complex interactions in the regulation of gene expression in 
those tissues. 
CONCLUSION 
• Since the expression of the cystatin S gene in respon 
se to IPR in surgically, bilateral and unilateral, sympathectomiz- 
ed and chemically, reserpine, denervated SMG is reduced to 
about the same extent and not totally suppressed, suggests that 
other factor(s) in addition to the p-adrenergic pathway partici 
pate in its regulation. In addition to norepinephrine, the major 
neurotransmitter in the sympathetic nerve terminals, other neu- 
rotransmitters or neuropeptides are also depleted by sympath- 
ectomy. It is possible that one or more of these factors parti 
cipate in the induction of the cystatin S gene by IPR. Interest 
ingly, the concentrations of VIP, CGRP and SP are increasing 
during development of the SMG when the cystatin S gene is 
maximally expressed (117). Furthermore, since the two branches 
of the autonomic nervous system act in parallel in the SMG, the 
parasympathetic nerve terminals may also provide factor(s) that 
are candidates for playing a role in IPR-induced expression of 
the cystatin S gene. Collectively, the evidence suggests that the 
regulation of the cystatin S gene is orchestrated by a complex 
set of neural, hormonal, and developmental factors. 
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